Skip to main content

Advertisement

Log in

Acute esophageal necrosis complicating diabetic ketoacidosis in a patient with type II diabetes mellitus and excessive cola consumption: a case report

  • Case Report
  • Published:
Diabetology International Aims and scope Submit manuscript

Abstract

Acute esophageal necrosis (AEN) implicates poor tissue perfusion, functionally defective mucosal barrier, and corrosive injury of the esophageal mucosa, typically characterized by diffuse, circumferential greyish or black discoloration of the esophagus in esophagogastroduodenoscopy. Low-volume states, as diabetic ketoacidosis (DKA), predispose to AEN. Cola drinks diminish the esophageal pH by decreasing the lower esophageal sphincter pressure. We report a 47-year-old male shepherd with chest pain, nausea, odynophagia and gradual decline in level of consciousness, who reported consumption of 6–7 L of cola beverages per day, and was diagnosed with DKA. The patient had a record of type 2 diabetes mellitus and coronary heart disease, and he was administered empagliflozin 25 mg q24 hours, vildagliptin 50 mg bid, metformin 1000 mg bid, and insulin glargine 24 IU q 24. Esophagogastroduodenoscopy was indicative of a diffuse, edematous, and eroded mucosa of grey colour from the upper to the lower esophageal sphincter. CT scan supported the diagnosis, revealing diffuse thickening and edematous imaging of the esophageal wall with an abnormal edge of the mucosa in the lower half of the esophagus. Seven days after rigorous treatment with fluid resuscitation, insulin restoration, esomeprazole, fluconazole, cefoxitine, and metronidazole, the patient was ameliorated. A second endoscopy revealed obvious improvement. Pathophysiology, diagnosis, and treatment of DKA/AEN intertwining are thoroughly discussed. In conclusion, clinicians should not disregard AEN in the differential diagnosis of patients with DKA and clinical symptoms of esophagitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Gurvits GE. Black esophagus: acute esophageal necrosis syndrome. World J Gastroenterol. 2010;16:3219–25.

    Article  Google Scholar 

  2. Dias E, Santos-Antunes J, Macedo G. Diagnosis and management of acute esophageal necrosis. Ann Gastroenterol. 2019;32:529–40.

    PubMed  PubMed Central  Google Scholar 

  3. Rubinstein E, Hauge C, Sommer P, Mortensen T. Oesophageal and gastric potential difference and pH in healthy volunteers following intake of coca-cola, red wine, and alcohol. Pharmacol Toxicol. 1993;72:61–5.

    Article  CAS  Google Scholar 

  4. Shukla A, Meshram M, Gopan A, Ganjewar V, Kumar P, Bhatia SJ. Ingestion of a carbonated beverage decreases lower esophageal sphincter pressure and increases frequency of transient lower esophageal sphincter relaxation in normal subjects. Indian J Gastroenterol. 2012;31:121–4.

    Article  Google Scholar 

  5. McCloy RF, Greenberg GR, Baron JH. Duodenal pH in health and duodenal ulcer disease: effect of a meal, Coca-Cola, smoking, and cimetidine. Gut. 1984;25:386–92.

    Article  CAS  Google Scholar 

  6. Kapicioğlu S, Baki A, Reis A, Tekelioğlu Y. Cola drinks consumption and oesophagitis. Dis Esophagus. 1999;12:306–8.

    Article  Google Scholar 

  7. Muneer M, Akbar I. Acute metabolic emergencies in diabetes: DKA, HHS and EDKA. Adv Exp Med Biol. 2021;1307:85–114.

    Article  CAS  Google Scholar 

  8. Rigolon R, Fossà I, Rodella L, Targher G. Black esophagus syndrome associated with diabetic ketoacidosis. World J Clin Cases. 2016;4:56–9.

    Article  Google Scholar 

  9. Mimidis K, Papadopoulos V, Margaritis V, Thomopoulos K, Gatopoulou A, Nikolopoulou V, Kartalis G. Predisposing factors and clinical symptoms in HIV-negative patients with Candida oesophagitis: are they always present? Int J Clin Pract. 2005;59:210–3.

    Article  CAS  Google Scholar 

  10. Kim YH, Choi SY. Black esophagus with concomitant candidiasis developed after diabetic ketoacidosis. World J Gastroenterol. 2007;13:5662–3.

    Article  Google Scholar 

  11. Shah AR, Landsman M, Waghray N. A dire presentation of diabetic ketoacidosis with "black esophagus. Cureus. 2019;11:e4761.

    PubMed  PubMed Central  Google Scholar 

  12. Oezcelik A, DeMeester SR. General anatomy of the esophagus. Thorac Surg Clin. 2011;21:289–97.

    Article  Google Scholar 

  13. Büsing F, Hägele FA, Nas A, Döbert LV, Fricker A, Dörner E, Podlesny D, Aschoff J, Pöhnl T, Schweiggert R, Fricke WF, Carle R, Bosy-Westphal A. High intake of orange juice and cola differently affects metabolic risk in healthy subjects. Clin Nutr. 2019;38:812–9.

    Article  Google Scholar 

  14. Love IY, Perl S, Rapoport MJ. A rare case of caffeine storm due to excessive coca-cola consumption. Isr Med Assoc J. 2016;18:366–7.

    PubMed  Google Scholar 

  15. Tsimihodimos V, Kakaidi V, Elisaf M. Cola-induced hypokalaemia: pathophysiological mechanisms and clinical implications. Int J Clin Pract. 2009;63:900–2.

    Article  CAS  Google Scholar 

  16. Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, Januzzi J, Verma S, Tsutsui H, Brueckmann M, Jamal W, Kimura K, Schnee J, Zeller C, Cotton D, Bocchi E, Böhm M, Choi DJ, Chopra V, Chuquiure E, Giannetti N, Janssens S, Zhang J, Gonzalez Juanatey JR, Kaul S, Brunner-La Rocca HP, Merkely B, Nicholls SJ, Perrone S, Pina I, Ponikowski P, Sattar N, Senni M, Seronde MF, Spinar J, Squire I, Taddei S, Wanner C, Zannad F, EMPEROR-Reduced Trial Investigators. Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med. 2020;383:1413–24.

    Article  CAS  Google Scholar 

  17. Taylor SI, Blau JE, Rother KI. SGLT2 inhibitors may predispose to ketoacidosis. J Clin Endocrinol Metab. 2015;100:2849–52.

    Article  CAS  Google Scholar 

  18. Ferrannini E, Baldi S, Frascerra S, Astiarraga B, Heise T, Bizzotto R, Mari A, Pieber TR, Muscelli E. Shift to fatty substrate utilization in response to sodium-glucose cotransporter 2 inhibition in subjects without diabetes and patients with type 2 diabetes. Diabetes. 2016;65:1190–5.

    Article  CAS  Google Scholar 

  19. Douros A, Lix LM, Fralick M, Dell’Aniello S, Shah BR, Ronksley PE, Tremblay É, Hu N, Alessi-Severini S, Fisher A, Bugden SC, Ernst P, Filion KB. Sodium-glucose cotransporter-2 inhibitors and the risk for diabetic ketoacidosis: a multicenter cohort study. Ann Intern Med. 2020;173:417–25.

    Article  Google Scholar 

  20. Jeyalingam T, Shimamura Y, Teshima C. Endoscopic resolution of black esophagus with treatment of diabetic ketoacidosis. Clin Gastroenterol Hepatol. 2018;16:e68–9.

    Article  Google Scholar 

  21. Sandhu S, Wang T, Prajapati D. Acute esophageal necrosis complicated by refractory stricture formation. JGH Open. 2021;5:528–30.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vasileios Papadopoulos.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Human rights statement and informed consent

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (permission was obtained by the Xanthi General Hospital Scientific Committee-Decision No 104, May 17, 2021), as well as the Helsinki Declaration of 1964 and later version. Informed consent or substitute for it was obtained from the patient.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Avramidou, D., Violatzi, P., Zikoudi, DG. et al. Acute esophageal necrosis complicating diabetic ketoacidosis in a patient with type II diabetes mellitus and excessive cola consumption: a case report. Diabetol Int 13, 315–319 (2022). https://doi.org/10.1007/s13340-021-00537-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13340-021-00537-y

Keywords

Navigation